CTLA4 and neoplasm: For instance, the expression of programmed cell death protein 1 (PD-1/CD279) and check-point blockade of cytotoxic T lymphocyte antigen 4 (CTLA-4/CD152) may differ among tumor-infiltrating lymphocytes compared to circulating T cells [70].